The a2 Milk Company™ is in the business of pioneering a2 Milk™ and making its unique health benefits understood and available to everybody around the world
The Annual Report for The a2 Milk Company Limited is now available to view online
Company announces exceptional growth with an increasing focus on nutritional products
a2 Milk™ creates an impact in an interactive outdoor event in California
Synlait Milk Limited and The a2 Milk Company Limited are pleased to announce a new supply agreement for the production of a2 Platinum® infant formula
Extent of Lactose Intolerance may be overstated, according to new human study
The a2 Milk Company Limited achieved a substantial lift in revenue and earnings in the 2016 financial year, with continued growth in the ANZ and China markets, and further progress in its targeted investment in a number of international markets.
The a2 Milk Company Limited is pleased to announce its admission to the S&P/ASX 200 Index effective after the close of trading on 17 June 2016.
Results of a human clinical trial show that A1 protein in cows’ milk may trigger symptoms of lactose intolerance. a2 Milk™, naturally free from A1 protein, potential solution for millions.
The New Zealand Government today awarded a $NZ1.15 million High-Value Nutrition research grant to AgResearch Limited to undertake research to validate the benefits of A2 beta casein protein contained in milk-based products on digestive function
The a2 Milk Company Limited is a dual listed on the NZX and ASX.
Visit our Investor Centre for up-to-date information about our company and our performance.
